• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从已发表证据中估计转移概率:决策模型构建者的教程。

Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers.

机构信息

Department of Health Management and Policy, UCLA School of Public Health, Los Angeles, CA, USA.

Health Economics Resource Center, VA Palo Alto Health Care System, Menlo Park, CA, USA.

出版信息

Pharmacoeconomics. 2020 Nov;38(11):1153-1164. doi: 10.1007/s40273-020-00937-z.

DOI:10.1007/s40273-020-00937-z
PMID:32797380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7426391/
Abstract

This tutorial presents practical guidance on transforming various types of information published in journals, or available online from government and other sources, into transition probabilities for use in state-transition models, including cost-effectiveness models. Much, but not all, of the guidance has been previously published in peer-reviewed journals. Our purpose is to collect it in one location to serve as a stand-alone resource for decision modelers who draw most or all of their information from the published literature. Our focus is on the technical aspects of manipulating data to derive transition probabilities. We explain how to derive model transition probabilities from the following types of statistics: relative risks, odds, odds ratios, and rates. We then review the well-known approach for converting probabilities to match the model's cycle length when there are two health-state transitions and how to handle the case of three or more health-state transitions, for which the two-state approach is not appropriate. Other topics discussed include transition probabilities for population subgroups, issues to keep in mind when using data from different sources in the derivation process, and sensitivity analyses, including the use of sensitivity analysis to allocate analyst effort in refining transition probabilities and ways to handle sources of uncertainty that are not routinely formalized in models. The paper concludes with recommendations to help modelers make the best use of the published literature.

摘要

本教程提供了实用的指导,介绍如何将期刊上发表的或从政府和其他来源在线获取的各种类型的信息转化为用于状态转移模型(包括成本效益模型)的转移概率。虽然大部分(但不是全部)指导先前已在同行评议期刊上发表过,但我们将其收集在一个位置,为主要或全部从已发表文献中提取信息的决策模型制作者提供一个独立的资源。我们的重点是处理数据以推导出转移概率的技术方面。我们解释了如何从以下类型的统计数据中推导出模型转移概率:相对风险、胜算、优势比和比率。然后,我们回顾了在有两个健康状态转移时将概率转换为匹配模型周期长度的方法,以及在有三个或更多健康状态转移时的处理方法,对于这种情况,两状态方法不适用。讨论的其他主题包括人群亚组的转移概率、在推导过程中使用来自不同来源的数据时需要注意的问题以及敏感性分析,包括使用敏感性分析来分配分析师在改进转移概率方面的工作以及处理模型中未常规形式化的不确定性来源的方法。本文最后提出了一些建议,以帮助模型制作者充分利用已发表的文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b007/7426391/0b3b1f86b301/40273_2020_937_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b007/7426391/45e8b1ebee38/40273_2020_937_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b007/7426391/0b3b1f86b301/40273_2020_937_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b007/7426391/45e8b1ebee38/40273_2020_937_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b007/7426391/0b3b1f86b301/40273_2020_937_Fig2_HTML.jpg

相似文献

1
Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers.从已发表证据中估计转移概率:决策模型构建者的教程。
Pharmacoeconomics. 2020 Nov;38(11):1153-1164. doi: 10.1007/s40273-020-00937-z.
2
An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example.使用成本效益分析示例的 R 中队列状态转换模型入门教程。
Med Decis Making. 2023 Jan;43(1):3-20. doi: 10.1177/0272989X221103163. Epub 2022 Jun 30.
3
Generalisability in economic evaluation studies in healthcare: a review and case studies.医疗保健经济评估研究中的可推广性:综述与案例研究
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490.
4
Survival modeling for the estimation of transition probabilities in model-based economic evaluations in the absence of individual patient data: a tutorial.基于模型的经济评价中缺乏个体患者数据时的转移概率估计的生存建模:教程。
Pharmacoeconomics. 2014 Feb;32(2):101-8. doi: 10.1007/s40273-013-0123-9.
5
Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals.状态转移模型转移概率的估计:NICE 评估综述。
Pharmacoeconomics. 2021 Aug;39(8):869-878. doi: 10.1007/s40273-021-01034-5. Epub 2021 May 19.
6
Changing Cycle Lengths in State-Transition Models: Challenges and Solutions.状态转换模型中周期长度的变化:挑战与解决方案
Med Decis Making. 2016 Nov;36(8):952-64. doi: 10.1177/0272989X16656165. Epub 2016 Jul 1.
7
A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example.使用成本效益分析示例的 R 中时变队列状态转移模型教程。
Med Decis Making. 2023 Jan;43(1):21-41. doi: 10.1177/0272989X221121747. Epub 2022 Sep 16.
8
Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness.状态转移模型中转换概率的替代转换方法:有效性及对比较有效性和成本效益的影响。
Med Decis Making. 2019 Jul;39(5):509-522. doi: 10.1177/0272989X19851095. Epub 2019 Jun 28.
9
Correction to: Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers.对《从已发表证据中估计转移概率:决策建模人员指南》的勘误
Pharmacoeconomics. 2020 Nov;38(11):1277. doi: 10.1007/s40273-020-00958-8.
10
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.卫生技术评估中决策分析模型良好实践指南综述。
Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. doi: 10.3310/hta8360.

引用本文的文献

1
Value for health: how fortified infant cereals provide cost-effective solutions to iron deficiency anaemia in Egypt.健康价值:强化婴儿谷物如何为埃及缺铁性贫血提供具有成本效益的解决方案。
Front Nutr. 2025 Jul 15;12:1570683. doi: 10.3389/fnut.2025.1570683. eCollection 2025.
2
Cost-utility analysis of school-based depression prevention interventions for Thai adolescents with subsyndromal depression.针对患有亚综合征抑郁症的泰国青少年的校内抑郁症预防干预措施的成本效益分析。
BMC Psychiatry. 2025 Jul 7;25(1):684. doi: 10.1186/s12888-025-06984-0.
3
Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies.

本文引用的文献

1
Log Odds and the Interpretation of Logit Models.对数几率与逻辑回归模型的解释。
Health Serv Res. 2018 Apr;53(2):859-878. doi: 10.1111/1475-6773.12712. Epub 2017 May 30.
2
A Procedure for Deriving Formulas to Convert Transition Rates to Probabilities for Multistate Markov Models.一种将转移率转换为多状态马尔可夫模型概率的公式推导方法。
Med Decis Making. 2017 Oct;37(7):779-789. doi: 10.1177/0272989X17696997. Epub 2017 Apr 5.
3
Extrapolation of Survival Data in Cost-effectiveness Analyses: The Need for Causal Clarity.成本效益分析中生存数据的外推:因果关系明确的必要性。
中东地区药品的决策分析模型:经济评估研究的系统评价
Appl Health Econ Health Policy. 2025 Apr 12. doi: 10.1007/s40258-024-00940-x.
4
Calibration of transition probabilities to model survival of adjuvant trastuzumab for early breast cancer in Indonesia.校准转移概率以模拟印度尼西亚早期乳腺癌辅助曲妥珠单抗治疗的生存率。
Int J Technol Assess Health Care. 2025 Mar 26;41(1):e18. doi: 10.1017/S0266462325000157.
5
The natural history of ductal carcinoma in situ: development, validation, and estimated outcomes of the SimDCIS model.导管原位癌的自然史:SimDCIS模型的开发、验证及预期结果
Breast Cancer Res Treat. 2025 May;211(1):223-231. doi: 10.1007/s10549-025-07639-0. Epub 2025 Mar 1.
6
TB antigen-based skin tests and QFT-Plus for Mycobacterium tuberculosis infection diagnosis in Brazilian healthcare workers: a cost-effectiveness analysis.基于结核分枝杆菌抗原的皮肤试验和QFT-Plus用于巴西医护人员结核分枝杆菌感染诊断的成本效益分析
Cad Saude Publica. 2025 Feb 24;41(1):e00178623. doi: 10.1590/0102-311XEN178623. eCollection 2025.
7
Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom Analysis.分子检测用于宫颈癌筛查的分流:使用余量分析的经济评估
Cancers (Basel). 2025 Feb 11;17(4):612. doi: 10.3390/cancers17040612.
8
Dapagliflozin for the treatment of heart failure with reduced ejection fraction in Brazil: a cost-effectiveness analysis.达格列净用于治疗巴西射血分数降低的心力衰竭:一项成本效益分析。
Lancet Reg Health Am. 2024 Dec 28;42:100968. doi: 10.1016/j.lana.2024.100968. eCollection 2025 Feb.
9
Evaluation of the Soda Tax on Obesity and Diabetes in California: A Cost-Effectiveness Analysis.加利福尼亚州汽水税对肥胖和糖尿病影响的评估:成本效益分析
MDM Policy Pract. 2025 Jan 13;10(1):23814683241309669. doi: 10.1177/23814683241309669. eCollection 2025 Jan-Jun.
10
Multiple myeloma: What is the most cost-effective imaging strategy for initial detection of bone lesions?多发性骨髓瘤:对于骨病变的初始检测,最具成本效益的成像策略是什么?
Skeletal Radiol. 2025 May;54(5):1081-1091. doi: 10.1007/s00256-024-04810-4. Epub 2024 Oct 28.
Med Decis Making. 2017 May;37(4):337-339. doi: 10.1177/0272989X17697019. Epub 2017 Mar 29.
4
Trends in Postpartum Depressive Symptoms - 27 States, 2004, 2008, and 2012.2004年、2008年和2012年27个州产后抑郁症状的趋势
MMWR Morb Mortal Wkly Rep. 2017 Feb 17;66(6):153-158. doi: 10.15585/mmwr.mm6606a1.
5
What Pertussis Mortality Rates Make Maternal Acellular Pertussis Immunization Cost-Effective in Low- and Middle-Income Countries? A Decision Analysis.在低收入和中等收入国家,何种百日咳死亡率会使孕产妇无细胞百日咳免疫接种具有成本效益?一项决策分析。
Clin Infect Dis. 2016 Dec 1;63(suppl 4):S227-S235. doi: 10.1093/cid/ciw558.
6
Extrapolation of Survival Curves from Cancer Trials Using External Information.利用外部信息对癌症试验的生存曲线进行外推
Med Decis Making. 2017 May;37(4):353-366. doi: 10.1177/0272989X16670604. Epub 2016 Sep 29.
7
Changing Cycle Lengths in State-Transition Models: Challenges and Solutions.状态转换模型中周期长度的变化:挑战与解决方案
Med Decis Making. 2016 Nov;36(8):952-64. doi: 10.1177/0272989X16656165. Epub 2016 Jul 1.
8
Bayesian Solutions for Handling Uncertainty in Survival Extrapolation.用于处理生存外推中不确定性的贝叶斯解决方案。
Med Decis Making. 2017 May;37(4):367-376. doi: 10.1177/0272989X16650669. Epub 2016 Jun 8.
9
Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods.利用外部数据从随机试验推断生存率:方法综述
Med Decis Making. 2017 May;37(4):377-390. doi: 10.1177/0272989X16639900. Epub 2016 Jul 10.
10
Estimating population attributable fractions to quantify the health burden of obesity.估算人群归因分数以量化肥胖的健康负担。
Ann Epidemiol. 2015 Mar;25(3):201-7. doi: 10.1016/j.annepidem.2014.11.010. Epub 2014 Nov 13.